Cumberland Pharmaceuticals (CPIX) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | -3,225.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -476.15% |
| Mar 31, 2026 | -143.69% |
| Dec 31, 2025 | -6.19% |
| Sep 30, 2025 | 14.08% |
| Jun 30, 2025 | 33.69% |
| Mar 31, 2025 | 91.53% |
| Dec 31, 2024 | 60.26% |
| Sep 30, 2024 | 43.57% |
| Jun 30, 2024 | 80.34% |
| Mar 31, 2024 | -50.25% |
| Dec 31, 2023 | 7.02% |
| Sep 30, 2023 | -2.77% |
| Jun 30, 2023 | 26.08% |
| Mar 31, 2023 | -61.74% |
| Dec 31, 2022 | 44.82% |
| Sep 30, 2022 | -10.78% |
| Jun 30, 2022 | -114.37% |
| Mar 31, 2022 | -70.78% |
| Dec 31, 2021 | -111.48% |
| Sep 30, 2021 | 77.23% |